Efficacy ofeverolimus plusoctreotide LAR inpatients withadvancedneuroendocrine tumorand carcinoidsyndrome Marianne PavelÉric BaudinKjell E. Öberg2017 год

Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
статья из журнала